Zefia Watson

Bachelor of Medicine and Bachelor of Science,  Massachusetts General Hospital 

Location: United States

Consulting Services

Legal Support Admin and Customer Support Biostatistics Hospital-Pharmacy-Insurance Career Advice and Mentoring

Areas Of Interest

Changes, Climate Tilade Basal Cell Epitheliomas Aropax Gene, src Paranoid Schizophrenias Meningioma, Parasagittal IDEC-C2B8 Helper Inducer T Lymphocytes Isobutyl alpha Cyanoacrylate Cranial Nerve, Third beta Isopropylmalate Dehydrogenase Base Composition Cytochrome P-450 CYP21 Subacute Necrotizing Encephalomyelitis, Infantile Chalconoids Tunica Adventitia Macrophage, Bone Marrow-Derived Serpula hyodysenteriae Malonitrile, ortho-Chlorobenzylidene Verbal Fluency Disorders Opinion, Second HX575 Compound Daily Intake, Acceptable Loudness Perceptions ras GTPase Activating Proteins Melanotropin Regulatory Factors, Myogenic

Professional Narrative

Dr. Zefia Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Medical Writer, Harvard Med 2009
Executive Director, Harvard Med 2015

Education

Director Medicine, Baylor College 2001
Bachelor of science in nursing, Yale School of Medicine 1997

Referees

Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02